Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

NCT01165996

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Interleukin-2 in Treating Patients With Myelodysplastic Syndrome

NCT00002746

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality

NCT00874978

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: King's College Hospital NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

CAMELLIA: Anti-CD47 Antibody Therapy in Haematological Malignancies

NCT02678338

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: University Hospital of Wales Cardiff, United Kingdom

St. James University Hospital Leeds, United Kingdom

The Royal Liverpool University Hospital Liverpool, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

View Trial Details

Completed

Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy

NCT01980056

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Weill Cornell Medical College New York, United States

View Trial Details

Completed

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

NCT02296242

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UCLA Medical Center Los Angeles, California, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome

NCT02363491

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Research Site Tampa, Florida, United States

Research Site New York, United States

Research Site The Bronx, New York, United States

Research Site Houston, Texas, United States

View Trial Details

Completed

Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome

NCT03337451

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Research Site Houston, Texas, United States

View Trial Details

Completed

Development of an in Vitro Hematopoietic Culture System and Application to Myelodysplastic Syndromes.

NCT03107273

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematopoietic Cell Proliferation, +2 more
Locations: CHU Amiens Picardie Amiens, Picardie, France

View Trial Details

Completed

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

NCT01634217

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +38 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions